PlainRecalls
FDA Drug Low Class III Terminated

COSOPT Ophthalmic Solution, USP, (2% Dorzolamide Hydrochloride, 0.5% Timolol Maleate), 10 mL dropper bottle, Sterile, Rx only, Distributed by: Akorn, Inc., Lake Forest, IL, NDC: 17478-605-10

Reported: February 20, 2019 Initiated: December 20, 2018 #D-0483-2019

Product Description

COSOPT Ophthalmic Solution, USP, (2% Dorzolamide Hydrochloride, 0.5% Timolol Maleate), 10 mL dropper bottle, Sterile, Rx only, Distributed by: Akorn, Inc., Lake Forest, IL, NDC: 17478-605-10

Reason for Recall

Failed Stability Specifications: out of specification results for opalescence at 7 month stability study.

Details

Recalling Firm
Akorn Inc
Units Affected
30,794 bottles
Distribution
Nationwide USA and Puerto Rico
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
COSOPT Ophthalmic Solution, USP, (2% Dorzolamide Hydrochloride, 0.5% Timolol Maleate), 10 mL dropper bottle, Sterile, Rx only, Distributed by: Akorn, Inc., Lake Forest, IL, NDC: 17478-605-10. Recalled by Akorn Inc. Units affected: 30,794 bottles.
Why was this product recalled?
Failed Stability Specifications: out of specification results for opalescence at 7 month stability study.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 20, 2019. Severity: Low. Recall number: D-0483-2019.